Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
PRIVISCL.NS
BuyPremium GrowerPrivi Speciality Chemicals Limited · Basic Materials · India · $1.4B · Avg Vol: $3M/d
COMPANY DESCRIPTION
Privi Speciality Chemicals Limited, together with its subsidiaries, manufactures, supplies, and trades in aroma and fragrance chemicals in India and internationally.
FINANCIAL SUMMARY (INR)
| Year | 2023 | 2024 | 2025 | 2026 | CAGR | TTM | 2027E | 2028E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 16.1B | 17.5B | 20.9B | 25.4B | 16.6% | 26.7B | 30.2B | 39.4B | 24.5% |
| EPS (INR) | 5.45 | 24.30 | 47.30 | 81.08 | 145.9% | 86.74 | 100.81 | 134.92 | 29.0% |
| Shares | 39.1M | 39.1M | 39.1M | 39.1M | 0.0% | 39.1M | — | — | — |
| Debt | 10.8B | 10.1B | 11.4B | 10.2B | -1.8% | 10.7B | — | — | — |
| Equity | 8.3B | 9.2B | 11.0B | 14.1B | 19.4% | — | — | — | — |
| Op CF | 487.6M | 3.5B | 2.8B | 5.5B | 124.3% | 5.5B | — | — | — |
| Inv CF | -1.3B | -1.8B | -2.9B | -3.6B | — | — | — | — | — |
| Fin CF | 723.1M | -1.7B | 386.3M | -2.0B | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Basic Materials, ranked by industry match, size, and score similarity. Cross-listings of PRIVISCL.NS are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| PRIVISCL.NS | Privi Speciality Chemicals Limited(you) | $1.4B | 74 | Buy |
| PCBL.NS | PCBL Chemical Limited | $1.4B | 73 | Buy |
| KANSAINER.NS | Kansai Nerolac Paints Limited | $1.6B | 73 | Buy |
| SHAILY.NS | Shaily Engineering Plastics Limited | $1.7B | 73 | Buy |
| FINEORG.NS | Fine Organic Industries Limited | $1.7B | 73 | Buy |
| GRWRHITECH.NS | Garware Hi-Tech Films Limited | $1.7B | 72 | Buy |
| BASF.NS | BASF India Limited | $1.7B | 69 | Buy |
| SPLPETRO.NS | Supreme Petrochem Limited | $1.6B | 67 | Buy |
| ALKYLAMINE.NS | Alkyl Amines Chemicals Limited | $1.1B | 69 | Buy |
| JUBLINGREA.NS | Jubilant Ingrevia Limited | $1.1B | 66 | Buy |
Peer medians: ROE 10.1% · P/E 24.3x · Gross margin 38.4%